Higher Odds of Dupilumab Prescriptions for Black Patients with Atopic Dermatitis: Results of a Retrospective Study Using DataDerm, The Database of The American Academy of Dermatology (AAD) - Supplemental Material

Name: Higher Odds of Dupilumab Prescriptions for Black Patients with Atopic Dermatitis: Results of a Retrospective Study Using DataDerm, The Database of The American Academy of Dermatology (AAD) - Supplemental Material
Creator: Mindy Szeto
Published: 2025-01-15T19:27:05.195Z
Keywords: Dermatology, Biologic Therapy, Atopic Dermatitis, Disparity

Szeto, Mindy; Rodriguez, Ramiro; Hydol-Smith, Jourdan; Burnette, Colin; Aninos, Arik; Kaye, Toni; Schilling, Lisa; Dellavalle, Robert

doi:10.17632/gxhxzxwyyg.1

Higher Odds of Dupilumab Prescriptions for Black Patients with Atopic Dermatitis: Results of a Retrospective Study Using DataDerm, The Database of The American Academy of Dermatology (AAD) - Supplemental Material

Published: 15 January 2025| Version 1 | DOI: 10.17632/gxhxzxwyyg.1

Contributors:

Mindy Szeto, Ramiro Rodriguez, Jourdan Hydol-Smith, Colin Burnette, Arik Aninos, Toni Kaye, Lisa Schilling, Robert Dellavalle

Description

Higher Odds of Dupilumab Prescriptions for Black Patients with Atopic Dermatitis: Results of a Retrospective Study Using DataDerm, The Database of The American Academy of Dermatology (AAD) - Supplemental Material. Supplemental Table I. Demographics of Dupilumab Prescriptions in Atopic Dermatitis Patients by Age, Sex, Race/Ethnicity, and Insurance Status. Supplemental Table II. Variables Requested from DataDerm. Supplemental Table III. DataDerm Patients Extracted and Inclusion Criteria.

Higher Odds of Dupilumab Prescriptions for Black Patients with Atopic Dermatitis: Results of a Retrospective Study Using DataDerm, The Database of The American Academy of Dermatology (AAD) - Supplemental Material

Description

Files

Categories

Licence